|5th January 2021||Paula Ragan||2,400||Open or private sale||$7.00||$16,800.00|
|23rd December 2020||Paula Ragan||4,800||Open or private sale||$7.00||$33,600.00|
|5th October 2020||Paula Ragan||1,797||Open or private sale||$7.00||$12,579.00|
|2nd October 2020||Paula Ragan||603||Open or private sale||$7.00||$4,221.00|
|21st September 2020||Adam S. Mostafa||10,834||Open or private sale||$7.08||$76,704.72|
|9th September 2020||Paula Ragan||8,840||Open or private sale||$8.04||$71,073.60|
|9th September 2020||Derek M Meisner||8,334||Open or private sale||$8.05||$67,088.70|
|9th September 2020||Renato Skerlj||5,834||Open or private sale||$8.05||$46,963.70|
|2nd September 2020||Paula Ragan||2,400||Open or private sale||$7.99||$19,176.00|
|17th August 2020||Adam S. Mostafa||16,250||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Biotechnology company engages in developing human antibodies for treating infectious diseases. Operates as a biotechnology company which engages indeveloping human antibodies.